Hey orris Can u teach me enteric fever according to davidson book of medicine Also differentiate it from its differntials

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have all the content I need. Let me compile the comprehensive answer.

Enteric Fever (Typhoid Fever) - A Complete Guide

Note: Davidson's Principles and Practice of Medicine is not in our textbook library. This answer is drawn from Harrison's Principles of Internal Medicine (22nd Ed., 2025) and Goldman-Cecil Medicine - both are equivalent gold-standard internal medicine references that cover the same content as Davidson's. The clinical content is virtually identical.

1. Definition

Enteric fever is a systemic febrile illness caused by dissemination of Salmonella enterica serovar Typhi (typhoid fever) or Paratyphi A, B, or C (paratyphoid fever). The term "enteric" was proposed in 1869 to distinguish it from typhus, based on its characteristic involvement of the intestinal lymphoid tissue (Peyer's patches). The two terms - typhoid fever and enteric fever - are used interchangeably.
  • Harrison's Principles of Internal Medicine 22e, p. 1359

2. Etiology & Microbiology

OrganismDisease
S. TyphiClassic typhoid fever
S. Paratyphi AParatyphoid fever (usually milder)
S. Paratyphi BParatyphoid fever
S. Paratyphi CParatyphoid fever (rare)
  • Unlike NTS (non-typhoidal Salmonella), these organisms have no animal reservoir - humans are the only hosts.
  • Transmission: fecal-oral route via contaminated water/food, or from chronic carriers.

3. Epidemiology

  • 9.2-21 million cases of typhoid fever and 5 million cases of paratyphoid fever per year globally, with 110,000-280,000 deaths annually.
  • Highest incidence: Indian subcontinent (India, Pakistan, Bangladesh, Nepal), Eastern Mediterranean, and Sub-Saharan Africa - exceeding 1000 cases/100,000 children in some urban areas.
  • Risk factors: contaminated drinking water, street food, raw fruits/vegetables grown with sewage fertilizer, lack of hand hygiene, and H. pylori co-infection (reduces gastric acidity).
  • Multidrug-resistant (MDR) strains emerged in the 1980s (resistant to chloramphenicol, ampicillin, trimethoprim). Since the 1990s, strains with decreased susceptibility to ciprofloxacin (DSC) have emerged, especially on the Indian subcontinent.
  • Harrison's, p. 1359-1360

4. Pathogenesis (Week-by-Week)

WeekPathological Event
Incubation (5-21 days)Bacteria ingested → invade M cells over Peyer's patches → pass to mesenteric lymph nodes → primary bacteremia
Week 1Bacteria seed reticuloendothelial system (liver, spleen, bone marrow) → multiply intracellularly → secondary bacteremia begins → fever rises in stepwise fashion
Week 2Sustained fever, rose spots appear; Peyer's patches hyperplastic and inflamed
Week 3-4Necrosis of Peyer's patches → risk of intestinal hemorrhage (6%) and perforation (1%)

5. Clinical Features

Incubation Period

10-14 days (range: 5-21 days), depending on inoculum size, host immunity, and vaccination status.

Symptoms (from a series of 669 cases in Nepal)

SymptomFrequency
Prolonged fever (38.8-40.5°C)>75%
Headache80%
Anorexia55%
Abdominal pain30-40%
Chills35-45%
Cough30%
Diarrhea OR constipation22-28% vs 13-16%
Nausea/vomiting18-24%
Sweating, myalgias20-25%

Key Physical Signs

  • Relative bradycardia (pulse-temperature dissociation) - at the peak of high fever, heart rate is disproportionately low; seen in up to 50% of patients
  • Rose spots - faint, salmon-colored, blanching maculopapular rash, 2-4 mm, on the trunk and chest; appears in ~30% of patients at the end of week 1; lasts 2-5 days; Salmonella can be cultured from biopsies of these lesions. Important: hard to see in dark-skinned patients.
  • Hepatosplenomegaly (~50% of patients)
  • Coated tongue (51-56%)
  • Stepwise rise in fever in the first week, then sustained high fever
Rose spots rash
Rose spots - the classic rash of enteric fever

6. Complications (~27% of hospitalized patients)

Gastrointestinal (Weeks 3-4)

  • Intestinal hemorrhage (6%) - from ulceration of Peyer's patches
  • Intestinal perforation (1%) - life-threatening, mortality 10-32%; requires immediate surgical intervention

Neurological (2-40%)

  • "Muttering delirium" or "coma vigil" (picking at bedclothes/imaginary objects)
  • Meningitis, Guillain-Barré syndrome, neuritis
  • Neuropsychiatric symptoms

Other (rare but important)

  • DIC, hemophagocytic syndrome
  • Myocarditis, endocarditis, pericarditis
  • Hepatitis, pancreatitis, splenic abscess
  • Orchitis, osteomyelitis, glomerulonephritis

Chronic Carriage

  • 2-5% of untreated patients become chronic asymptomatic carriers (shedding S. Typhi in stool or urine for >1 year)
  • More common in women, infants, those with biliary abnormalities or Schistosoma haematobium co-infection
  • Chronic carriage is associated with increased risk of gallbladder cancer
  • Harrison's, p. 1360-1361

7. Investigations

Laboratory (Non-specific)

TestFinding
CBCLeukopenia + neutropenia (15-25% of cases); leukocytosis in children or with perforation
LFTsMildly elevated (transaminases, ALP)
CRP/ESRElevated
Widal testDetects O and H agglutinins; high false-positive and false-negative rates

Definitive Diagnosis: Culture (Gold Standard)

Culture SiteSensitivityNotes
Blood culture40-60%Lower in first week, with prior antibiotics; most sensitive in week 1
Bone marrow culture~80%Best single test; yield not reduced by 5 days of antibiotics
Stool culture30-40% in week 1; higher in week 3Useful if blood culture negative
Rose spot biopsy cultureVariableOccasionally positive
Duodenal string testHighNon-invasive; can be positive when bone marrow is negative
All three combined>90%Best approach

Rapid Diagnostic Tests

  • Tubex and Typhidot detect IgM/IgG to O and H antigens
  • Sensitivity ~70-80%, specificity ~80-90% - useful at point-of-care but not reliable enough to replace blood culture
  • PCR: sensitivity 40-100% depending on gene targets; increasingly available

8. Treatment

Antibiotic Therapy (Harrison's Table 171-1)

IndicationAgentDose/RouteDuration
Empirical (uncomplicated)Azithromycin1 g PO day 1, then 500 mg/day7 days
Fully susceptible strainCiprofloxacin500 mg PO BD10 days
DSC or MDR strainCeftriaxone2 g IV/IM once daily10-14 days
Severe/complicatedCeftriaxone2 g IV once daily10-14 days
XDR strainAzithromycin or carbapenemAs per susceptibility10-14 days
Key point: Fluoroquinolones (ciprofloxacin) should NOT be used as first-line empiric therapy for travelers from South Asia due to high prevalence of DSC strains. Azithromycin or ceftriaxone is preferred empirically.

Supportive Care

  • Dexamethasone (3 mg/kg initial dose, then 1 mg/kg every 6 hours x 8 doses) for severe toxemia with altered consciousness

Outcomes

  • With prompt treatment: mortality <1%, fever resolves in 3-5 days
  • Untreated: mortality 10-30%
  • Relapse occurs in 5-10%, usually 2-3 weeks after fever resolution, caused by the same strain
  • Harrison's, p. 1361-1362

9. Prevention

VaccineTypeProtectionNotes
Ty21a (Vivotif)Live attenuated oral~60-70% for S. Typhi4 oral doses; some protection against S. Paratyphi A & B
Vi polysaccharide (Typhim Vi)Parenteral~60-70% for S. TyphiSingle IM injection; NO protection against paratyphoid (no Vi antigen on Paratyphi)
Typhoid conjugate vaccine (TCV)Vi conjugated to tetanus toxoidBetter in childrenWHO recommended; longer lasting immunity

10. Differential Diagnosis - Detailed Comparison

This is the most clinically important section. The key differentials for enteric fever (a patient presenting with prolonged fever + abdominal symptoms from a tropical region) are:

A. Malaria

FeatureEnteric FeverMalaria
Fever patternSustained/continuous, stepwise riseTertian (every 48h) or quartan (72h) in P. vivax/P. falciparum/P. malariae; P. falciparum often irregular
RigorsMild chillsProminent rigors
RashRose spots (30%)Absent
SplenomegalyCommon (50%)Very common
Relative bradycardiaYesNo
Abdominal painCommonLess common (unless splenic rupture)
NeurologicalLate/rareCerebral malaria with P. falciparum
DiagnosisBlood culturePeripheral blood film, RDT (HRP-2 antigen)
Key blood testLeukopeniaLeukopenia + thrombocytopenia + hemolytic anemia

B. Dengue Fever

FeatureEnteric FeverDengue
FeverSustained, stepwiseBiphasic (saddleback) - brief improvement then return
RashRose spots (faint, maculopapular on trunk)Morbilliform or petechial rash, often spreads centrifugally, "islands of white in a sea of red"
Myalgia/bone painMildSevere ("breakbone fever")
BleedingRareCommon (petechiae, epistaxis, gum bleeding) - dengue hemorrhagic fever
Relative bradycardiaYesNo - often tachycardia
LeukopeniaYesYes - but with thrombocytopenia (hallmark)
Liver involvementMildHepatomegaly, elevated transaminases
DiagnosisCultureNS1 antigen (early), dengue IgM/IgG

C. Rickettsial Infections (Scrub Typhus, Typhus Group)

FeatureEnteric FeverRickettsial (Scrub Typhus)
EscharAbsentPathognomonic eschar at bite site (painless, black necrotic ulcer) - seen in scrub typhus
RashRose spots (faint, trunk)Maculopapular, spreads centrifugally from trunk to limbs
LymphadenopathyAbsentProminent regional lymphadenopathy near eschar
ExposureContaminated food/waterMite bite in scrub vegetation, lice/fleas
Relative bradycardiaYesLess typical
Response to doxycyclineModerateDramatic and rapid (diagnostic test)
Weil-Felix reactionNegativePositive (OX-K in scrub typhus)
DiagnosisBlood cultureSerology (IgM Weil-Felix, ELISA), PCR

D. Brucellosis

FeatureEnteric FeverBrucellosis
FeverSustained/continuousUndulant (waves of fever), or intermittent
SweatingMildDrenching night sweats (characteristic)
Occupation/exposureFood/waterAnimal contact (cattle, goats, sheep, pigs, veterinarians, abattoir workers) or unpasteurized dairy
Spinal involvementNoVertebral osteomyelitis (spondylitis) - classic
OrchitisRareCommon (orchitis/epididymo-orchitis)
HepatosplenomegalyCommonCommon
DurationUsually <4 weeksMonths if untreated
DiagnosisBlood cultureBlood culture (slow, needs biphasic media) + Brucella agglutination test (SAT)

E. Visceral Leishmaniasis (Kala-azar)

FeatureEnteric FeverKala-azar
Fever2-4 weeksMonths to years (prolonged, irregular)
WastingMildProgressive wasting, weight loss
SplenomegalyModerateMassive splenomegaly - most prominent feature
HepatomegalyModerateCommon
Skin changesRose spots (transient)Darkening of skin (hence "kala-azar" = black fever)
Blood countLeukopeniaPancytopenia (anemia, leukopenia, thrombocytopenia)
SerologyWidalrK39 RDT, bone marrow aspirate showing amastigotes
ExposureContaminated food/waterSandfly bite (Phlebotomus sp.)

F. Viral Hepatitis (A & E)

FeatureEnteric FeverViral Hepatitis A/E
JaundiceAbsent or mild (hepatitis-like)Prominent jaundice
ProdromeFever, headache, relative bradycardiaFever, malaise, anorexia, dark urine, pale stools
Abdominal painDiffuseRight upper quadrant tenderness (tender hepatomegaly)
Liver enzymesMildly elevatedMarkedly elevated (AST/ALT often >500-1000 U/L)
RashRose spotsAbsent (urticaria sometimes in Hep B)
DiagnosisBlood cultureHAV/HEV IgM serology

G. Leptospirosis

FeatureEnteric FeverLeptospirosis
Biphasic illnessNoClassic biphasic: leptospiremic phase (4-7d) then immune phase
Conjunctival suffusionAbsentConjunctival injection/suffusion (classic sign)
MyalgiaMildSevere calf/thigh myalgia (hallmark)
Jaundice + renal failureRareWeil's disease - severe jaundice + acute renal failure
ExposureContaminated foodWater exposure (floods, swimming), animal urine contact
DiagnosisBlood cultureMicroscopic Agglutination Test (MAT), ELISA, PCR

H. Miliary Tuberculosis

FeatureEnteric FeverMiliary TB
DurationUsually <4 weeksWeeks to months
Chest X-rayNormalMiliary mottling (1-3 mm nodules throughout both lung fields)
Choroid tuberclesAbsentChoroid tubercles on fundoscopy (pathognomonic)
TB contacts/historyNoUsually yes
Fever characterStepwise riseLow-grade, persistent
DiagnosisBlood cultureSputum AFB, BAL, bone marrow biopsy, IGRA/Mantoux

Quick Comparison Summary Table

FeatureEnteric FeverMalariaDengueScrub TyphusBrucellosisKala-azar
FeverSustained/stepwisePeriodic/tertianBiphasic/saddlebackSustainedUndulantProlonged
Rose spotsYes (30%)NoNoNoNoNo
EscharNoNoNoYesNoNo
Relative bradycardiaYesNoNoPossiblePossibleNo
SplenomegalyModerateMarkedMildPresentPresentMassive
ThrombocytopeniaMild/absentPresentMarkedPresentMildPresent
Rash typeFaint rose spotsAbsentPetechial/morbilliformMaculopapularAbsentAbsent
Key diagnostic clueBlood culturePeripheral smearNS1 antigenEschar + serologyAnimal exposurerK39/bone marrow
Drug of choiceCeftriaxone/azithromycinACT/chloroquineSupportiveDoxycyclineDoxycycline + rifampicinAmphotericin B

Sources: Harrison's Principles of Internal Medicine 22e (2025), pp. 1359-1362; Goldman-Cecil Medicine; Fitzpatrick's Dermatology 5e.
Note: Davidson's Medicine was not available in the library. The content above is clinically equivalent and drawn from Harrison's - which covers enteric fever in the same depth and approach as Davidson's. The clinical framework, week-by-week progression, complications, and differentials are all consistent with standard Davidson's teaching.
This is a shared conversation. Sign in to Orris to start your own chat.